InterTech’s patented test technology eliminates the errors (both false positives and false negatives) inherent in previously used pressure testing methods.
A leading manufacturer of COVID-19 rapid testing systems has been able to triple production to help meet the demands of this global emergency—and do so with a savings of more than US$1 million.
Time-to-market for high throughput manufacture of fast clinical testing instruments was reduced by 50%.
Product quality traceability is assured by deterministic InterTech leak test technology that eliminates potential for lapses in human operator judgements over entire product lifecycle.
8
FEB
FEB
0